Upstream Bio (UPB) Restructuring Costs (2024 - 2026)

Upstream Bio's Restructuring Costs history runs 3 years deep, the most recent figure standing at $1.1 million for Q1 2026.

• On a quarterly basis, Restructuring Costs rose 5.6% year-over-year to $1.1 million in Q1 2026; TTM through Mar 2026 was $4.6 million, a 77.37% increase from a year earlier, with the FY2025 full-year figure at $4.5 million, up 127.77% from the prior year.
• Restructuring Costs slipped to $1.1 million in Q1 2026 per UPB's latest filing, from $1.3 million in the prior quarter.
• Across five years, Restructuring Costs topped out at $1.3 million in Q4 2025 and bottomed at $334000.0 in Q2 2024.
• The 3-year median for Restructuring Costs is $891000.0 (2025), against an average of $843666.7.
• Across the five-year window, Restructuring Costs jumped 273.95% in 2025 and climbed 5.6% in 2026, its largest moves.
• Year by year, Restructuring Costs stood at $836000.0 in 2024, then jumped by 56.58% to $1.3 million in 2025, then fell by 14.97% to $1.1 million in 2026.
• Per Business Quant, the three latest UPB Restructuring Costs figures stand at $1.1 million (Q1 2026), $1.3 million (Q4 2025), and $891000.0 (Q3 2025).